Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel Combinations in Advanced Pancreatic Cancer
NCT00004884Phase 2Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Jul 1999
- Primary completion
- Mar 2001
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of docetaxel in pancreatic adenocarcinoma (PDAC), sponsored by European Organisation for Research and Treatment of Cancer. Started Jul 1999; status: completed.
02
Drugs
docetaxel
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00004884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004884.